Logo image of MRBK

MERIDIAN CORP (MRBK) Stock Fundamental Analysis

NASDAQ:MRBK - Nasdaq - US58958P1049 - Common Stock - Currency: USD

15.6  -0.87 (-5.28%)

Fundamental Rating

3

Taking everything into account, MRBK scores 3 out of 10 in our fundamental rating. MRBK was compared to 405 industry peers in the Banks industry. MRBK has a bad profitability rating. Also its financial health evaluation is rather negative. MRBK is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

MRBK had positive earnings in the past year.
MRBK had a positive operating cash flow in the past year.
Each year in the past 5 years MRBK has been profitable.
The reported operating cash flow has been mixed in the past 5 years: MRBK reported negative operating cash flow in multiple years.
MRBK Yearly Net Income VS EBIT VS OCF VS FCFMRBK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.47%, MRBK is doing worse than 74.69% of the companies in the same industry.
With a Return On Equity value of 6.76%, MRBK is not doing good in the industry: 62.41% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 0.47%
ROE 6.76%
ROIC N/A
ROA(3y)0.78%
ROA(5y)1.19%
ROE(3y)10.71%
ROE(5y)14.46%
ROIC(3y)N/A
ROIC(5y)N/A
MRBK Yearly ROA, ROE, ROICMRBK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

MRBK has a Profit Margin of 10.80%. This is amonst the worse of the industry: MRBK underperforms 81.70% of its industry peers.
In the last couple of years the Profit Margin of MRBK has remained more or less at the same level.
MRBK does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 10.8%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-14.84%
PM growth 5Y-0.78%
GM growth 3YN/A
GM growth 5YN/A
MRBK Yearly Profit, Operating, Gross MarginsMRBK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1

2. Health

2.1 Basic Checks

MRBK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MRBK has been increased compared to 1 year ago.
Compared to 5 years ago, MRBK has less shares outstanding
Compared to 1 year ago, MRBK has an improved debt to assets ratio.
MRBK Yearly Shares OutstandingMRBK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
MRBK Yearly Total Debt VS Total AssetsMRBK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

MRBK has a debt to FCF ratio of 11.32. This is a negative value and a sign of low solvency as MRBK would need 11.32 years to pay back of all of its debts.
The Debt to FCF ratio of MRBK (11.32) is worse than 73.43% of its industry peers.
A Debt/Equity ratio of 1.16 is on the high side and indicates that MRBK has dependencies on debt financing.
The Debt to Equity ratio of MRBK (1.16) is worse than 87.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF 11.32
Altman-Z N/A
ROIC/WACCN/A
WACC17.49%
MRBK Yearly LT Debt VS Equity VS FCFMRBK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MRBK Yearly Current Assets VS Current LiabilitesMRBK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

6

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.48% over the past year.
The Earnings Per Share has been decreasing by -6.10% on average over the past years.
Looking at the last year, MRBK shows a quite strong growth in Revenue. The Revenue has grown by 11.32% in the last year.
The Revenue has been growing by 10.11% on average over the past years. This is quite good.
EPS 1Y (TTM)3.48%
EPS 3Y-38.52%
EPS 5Y-6.1%
EPS Q2Q%360%
Revenue 1Y (TTM)11.32%
Revenue growth 3Y-9.41%
Revenue growth 5Y10.11%
Sales Q2Q%14.08%

3.2 Future

The Earnings Per Share is expected to grow by 37.63% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 11.52% on average over the next years. This is quite good.
EPS Next Y47.43%
EPS Next 2Y37.63%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.14%
Revenue Next 2Y11.52%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
MRBK Yearly Revenue VS EstimatesMRBK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
MRBK Yearly EPS VS EstimatesMRBK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4 5

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.11, which indicates a correct valuation of MRBK.
Compared to the rest of the industry, the Price/Earnings ratio of MRBK is on the same level as its industry peers.
When comparing the Price/Earnings ratio of MRBK to the average of the S&P500 Index (29.62), we can say MRBK is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 8.89, the valuation of MRBK can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MRBK indicates a rather cheap valuation: MRBK is cheaper than 85.71% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, MRBK is valued rather cheaply.
Industry RankSector Rank
PE 13.11
Fwd PE 8.89
MRBK Price Earnings VS Forward Price EarningsMRBK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, MRBK is valued a bit cheaper than the industry average as 68.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.19
EV/EBITDA N/A
MRBK Per share dataMRBK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MRBK's earnings are expected to grow with 37.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.28
PEG (5Y)N/A
EPS Next 2Y37.63%
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.04%, MRBK has a reasonable but not impressive dividend return.
MRBK's Dividend Yield is comparable with the industry average which is at 3.19.
MRBK's Dividend Yield is a higher than the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 3.04%

5.2 History

MRBK has been paying a dividend for over 5 years, so it has already some track record.
MRBK has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
MRBK Yearly Dividends per shareMRBK Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

49.58% of the earnings are spent on dividend by MRBK. This is a bit on the high side, but may be sustainable.
DP49.58%
EPS Next 2Y37.63%
EPS Next 3YN/A
MRBK Yearly Income VS Free CF VS DividendMRBK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M
MRBK Dividend Payout.MRBK Dividend Payout, showing the Payout Ratio.MRBK Dividend Payout.PayoutRetained Earnings

MERIDIAN CORP

NASDAQ:MRBK (2/21/2025, 8:00:01 PM)

15.6

-0.87 (-5.28%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)01-24 2025-01-24/bmo
Earnings (Next)04-24 2025-04-24
Inst Owners61.6%
Inst Owner Change-70.06%
Ins Owners9.63%
Ins Owner Change0.78%
Market Cap175.34M
Analysts80
Price Target18.87 (20.96%)
Short Float %0.17%
Short Ratio0.37
Dividend
Industry RankSector Rank
Dividend Yield 3.04%
Yearly Dividend0.5
Dividend Growth(5Y)N/A
DP49.58%
Div Incr Years0
Div Non Decr Years1
Ex-Date02-10 2025-02-10 (0.125)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.96%
Min EPS beat(2)-5.73%
Max EPS beat(2)17.65%
EPS beat(4)1
Avg EPS beat(4)-18.49%
Min EPS beat(4)-82.7%
Max EPS beat(4)17.65%
EPS beat(8)3
Avg EPS beat(8)-11.4%
EPS beat(12)6
Avg EPS beat(12)-3.97%
EPS beat(16)10
Avg EPS beat(16)7.14%
Revenue beat(2)1
Avg Revenue beat(2)3.52%
Min Revenue beat(2)-0.35%
Max Revenue beat(2)7.39%
Revenue beat(4)3
Avg Revenue beat(4)1.97%
Min Revenue beat(4)-0.35%
Max Revenue beat(4)7.39%
Revenue beat(8)3
Avg Revenue beat(8)-2.1%
Revenue beat(12)4
Avg Revenue beat(12)-2.81%
Revenue beat(16)8
Avg Revenue beat(16)3.19%
PT rev (1m)8.82%
PT rev (3m)27.59%
EPS NQ rev (1m)-4.29%
EPS NQ rev (3m)-4.29%
EPS NY rev (1m)-5.75%
EPS NY rev (3m)-5.75%
Revenue NQ rev (1m)-1.06%
Revenue NQ rev (3m)-1.06%
Revenue NY rev (1m)2.41%
Revenue NY rev (3m)1.52%
Valuation
Industry RankSector Rank
PE 13.11
Fwd PE 8.89
P/S 1.67
P/FCF 10.19
P/OCF 9.66
P/B 1.05
P/tB 1.1
EV/EBITDA N/A
EPS(TTM)1.19
EY7.63%
EPS(NY)1.75
Fwd EY11.25%
FCF(TTM)1.53
FCFY9.82%
OCF(TTM)1.62
OCFY10.35%
SpS9.33
BVpS14.9
TBVpS14.18
PEG (NY)0.28
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.47%
ROE 6.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 10.8%
GM N/A
FCFM 16.42%
ROA(3y)0.78%
ROA(5y)1.19%
ROE(3y)10.71%
ROE(5y)14.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-14.84%
PM growth 5Y-0.78%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF 11.32
Debt/EBITDA N/A
Cap/Depr 67.4%
Cap/Sales 0.9%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 152.1%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC17.49%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.48%
EPS 3Y-38.52%
EPS 5Y-6.1%
EPS Q2Q%360%
EPS Next Y47.43%
EPS Next 2Y37.63%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.32%
Revenue growth 3Y-9.41%
Revenue growth 5Y10.11%
Sales Q2Q%14.08%
Revenue Next Year13.14%
Revenue Next 2Y11.52%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-42.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-43.27%
OCF growth 3YN/A
OCF growth 5YN/A